European Union - English - EMA (European Medicines Agency)

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older.fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Ireland - English - HPRA (Health Products Regulatory Authority)

ucb (pharma) ireland limited - hydroxyzine hydrochloride - film coated tablet - 25 milligram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - cetirizine hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - cetirizine hydrochloride - oral tablet - 10mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ucb pharma sa-nv - cetirizine dihydrochloride 10 mg - film-coated tablet - 10 mg - cetirizine dihydrochloride 10 mg - cetirizine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ucb pharma sa-nv - piracetam 1200 mg - film-coated tablet - 1200 mg - piracetam 1200 mg - piracetam

Australia - English - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - levetiracetam, quantity: 750 mg - tablet, film coated - excipient ingredients: macrogol 6000; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - keppra (film coated tablets and oral solution) is indicated for - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. - add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme), and - add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige). keppra concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - piracetam - tablet, film coated - 800 mg - piracetam 800.00 mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - piracetam -

Australia - English - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - olsalazine sodium -